In patients with BA, the IL-33/IL-13 pathway was correlated with liver fibrosis progression, in which IL-33 is secreted and binds ST2 receptors on mast cells to release IL-13/TGF-β1, which mediate the process of fibrosis (33). Here, IL33 is linked to Hepatic fibrosis.